Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ziconotide

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,402,310Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tersera Notes PACC Guidelines Update For PRIALT Administration
    Tersera Notes PACC Guidelines Update For PRIALT Administration

    23 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240723453532/en

    BUSINESSWIRE
    23 Jul 2024
    Share Share
    AmbioPharm Inc. Working with University of California Davis to Develop Non-Opioid Peptide-Based Pain Therapeutics
    AmbioPharm Inc. Working with University of California Davis to Develop Non-Opioid Peptide-Based Pain Therapeutics

    20 Jul 2021

    // PRESS RELEASE

    https://www.ambiopharm.com/news-press/ambiopharm-inc-working-with-university-of-california-davis-to-develop-non-opioid-peptide-based-pain-therapeutics/

    PRESS RELEASE
    20 Jul 2021
    Share Share
    Jazz Pharmaceuticals Enters Into Agreement with TerSera Therapeutics for Prialt
    Jazz Pharmaceuticals Enters Into Agreement with TerSera Therapeutics for Prialt

    29 Jun 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-enters-into-agreement-with-tersera-therapeutics-llc-for-prialt-300674775.html

    PR NEWSWIRE
    29 Jun 2018
    Share Share